Home > A. Molecular pathology > MUM1
MUM1
Monday 10 December 2012
Immunochemistry
Diffuse large B-cell lymphoma can be classified into two prognostically distinct subgroups with germinal center B-cell-like (CG) and activated B-cell-like (post-CG) characteristics, based on CD10, BCL-6, and MUM1 expression.
In primary mediastinal large B-cell lymphomas with homogeneous clinical characteristics, response to initial chemotherapy and MUM1 expression are associated with prognosis. (21623692)
Reference
Prognostic impact of MUM1 expression by immunohistochemistry on primary mediastinal large B-cell lymphoma. De Mello CA, De Andrade VP, De Lima VC, Carvalho AL, Soares FA. Leuk Lymphoma. 2011 Aug;52(8):1495-503. PMID: 21623692